Brian Schwartz
Chief Tech/Sci/R&D Officer chez INTENSITY THERAPEUTICS, INC.
Fortune : 35 550 $ au 31/03/2024
Profil
Brian D.
Schwartz is currently the Chief Medical Officer & Director at Cyclacel Pharmaceuticals, Inc. and a Director at Enlivex Therapeutics Ltd.
He is also the Executive VP-Clinical Development at Intensity Therapeutics, Inc. Previously, he worked as a Director at Infinity Pharmaceuticals, Inc. from 2021 to 2023 and as a Director at Mereo BioPharma Group Plc from 2020 to 2022.
He also served as an Independent Director at LifeSci Acquisition Corp.
in 2020.
From 2008 to 2020, he held the position of Chief Medical Officer and Head of Research & Development at ArQule, Inc. Additionally, he has experience as the Chief Medical Officer at Alaunos Therapeutics, Inc. Dr. Schwartz obtained his doctorate degree from the University of Pretoria in 1985.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/01/2024 | 15 205 ( 1,15% ) | 32 083 $ | 31/03/2024 | |
| 31/03/2023 | 914 ( 0,00% ) | 3 464 $ | 31/03/2024 | |
| 30/05/2023 | 30 919 ( 0,03% ) | 3 $ | 31/01/2024 |
Postes actifs de Brian Schwartz
| Sociétés | Poste | Début |
|---|---|---|
| ENLIVEX THERAPEUTICS LTD. | Director/Board Member | 01/12/2020 |
| CYCLACEL PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 25/01/2024 |
| INTENSITY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Brian Schwartz
| Sociétés | Poste | Fin |
|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Director/Board Member | 24/07/2023 |
| MEREO BIOPHARMA GROUP PLC | Director/Board Member | 10/11/2022 |
| VINCERX PHARMA, INC. | Director/Board Member | 23/12/2020 |
| ARQULE, INC. | Chief Tech/Sci/R&D Officer | 01/03/2020 |
| ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Brian Schwartz
| University of Pretoria | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| MEREO BIOPHARMA GROUP PLC | Health Technology |
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
